Neurocrine Biosciences
NBIX
NBIX
121 hedge funds and large institutions have $1.12B invested in Neurocrine Biosciences in 2014 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 54 increasing their positions, 23 reducing their positions, and 26 closing their positions.
Holders
121
Holders Change
+4
Holders Change %
+3.42%
% of All Funds
3.5%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
31
Increased
54
Reduced
23
Closed
26
Calls
$10.4M
Puts
$7.04M
Net Calls
+$3.37M
Net Calls Change
-$1.83M
Top Buyers
Top Sellers
1 |
1
Invesco
Atlanta,
Georgia
|
$11K |
2 |
2
State Street
Boston,
Massachusetts
|
$36.1M |
3 |
3
Millennium Management
New York
|
$0 |
4 |
VM
4
VHCP Management
New York
|
$4.89M |
5 |
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$11.9M |